MedTrace Logo

Pharmacogenetics for Pain Management in Joint Replacement Patients

NCT03772535 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2021-02-12

No results posted yet for this study

Summary

The purpose of this study is to determine the ability to use pharmacogenetic testing in a joint replacement practice to prescribe the most effective pain medicine for a specific patient.

Conditions

  • Arthroplasty Complications

Interventions

DIAGNOSTIC_TEST

Pharmacogenomics Testing

The doctor will use genetic test results to prescribe medications that are a most effective for subject.

Sponsors & Collaborators

  • Anderson Orthopaedic Research Institute

    lead OTHER

Principal Investigators

  • William Hamilton, MD · Anderson Orthopaedic Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-03
Primary Completion
2021-06-30
Completion
2021-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03772535 on ClinicalTrials.gov